PRFX (PainReform Ltd.) Earnings per share growth rate in current year
This daily chart on GURU.Markets for PainReform Ltd. (PRFX) shows the annual EPS variation, where the 0.00 mark indicates the yield level. This price action reflects Israeli developments of slow-release drug formulations. Growth prospects rely on the patent protection of the PRF-110 system, which is awaiting scaling across clinics. The result will be the integration of the drug delivery platform into surgical protocols, creating high switching costs for therapy.
Financial and market metric breakdowns for PainReform Ltd. (PRFX)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
Total Debt to Capital PainReform Ltd.|PRFX - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient painreform.com|PRFX - Company Debts|Debt to Book Value Ratio PainReform Corp|PRFX - Company Long-Term Debt|Company Short-Term Loans and Borrowings PainReform|Immediate Liquidity painreform.com
- net income and valuation multiples indicators:
PRFX - Net Profit|Forward Earnings PainReform Ltd.|PRFX - Price to Earnings Ratio|Projected Price to Earnings Ratio PainReform Corp|PRFX - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation PainReform Corp|PRFX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months PainReform|PRFX - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months painreform.com|PRFX - Earnings per share growth in current year|Net earnings per share growth forecast for next year PainReform Ltd.
Basic company analysis:PainReform Ltd
Low production costs for injectable formulas at PainReform Ltd. create powerful operating leverage, amplifying the impact of every sale on the bottom line. The eps_yy_co metric measures the annual growth rate of net income per share, capturing the efficiency of business scaling by calculating the difference between the current and previous periods. The current value of 0.00 in the YoY net income per share trend allows for an assessment of the company's maturity stage and helps avoid purchasing the asset at a historical peak.
Main competitors
Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Earnings per share growth in current year Amneal AMRX|PRGO (Perrigo Company PLC) - Earnings per share trend in current year|Alvotech Corp - Earnings growth in current year|LQDA - Earnings growth in current year|GLPG: Earnings growth in current year|ANIP - Expected net earnings per share growth this year|Earnings per share growth in current year MannKind|Earnings per share growth this year AMPH (Amphastar Pharmaceuticals Inc)|Earnings per share growth in current year Pacira (PCRX)|SPRY (ARS Corp) - Earnings per share increase in current year|Earnings growth in current year TBPH (Theravance Biopharma)|aquestive.com (AQST) - Earnings per share growth rate in current year|scPharma - Earnings growth in current year|Earnings per share trend in current year TECX|Tonix Pharmaceuticals Inc. (TNXP) - Earnings per share growth in current year|Earnings per share growth rate in current year China SXT Pharmaceuticals, Inc. (SXTC)|Earnings per share growth in current year Eupraxia Pharmaceuticals, Inc.|BHST: Earnings per share increase in current year|Earnings per share growth in current year eXoZymes (EXOZ)|Net earnings per share growth this year oramed.com ORMP|Entera Bio - Net earnings per share growth this year|Earnings per share increase in current year HYFT|ABVC - Earnings per share growth in current year|CPIX: Earnings per share growth in current year|QNTM (Quantum BioPharma) - Net earnings per share growth this year|FGEN: Net earnings per one share growth for the current year|TELO (Telomir Pharma) - Earnings growth in current year|Earnings per share growth this year RANI (Rani Therapeutics Inc)|Net earnings per share growth this year SNYR (Synergy CHC Corp)|Expected net earnings per share growth this year rallybio.com|Earnings per share growth in current year Lexaria Bioscience Corp. LEXX|PULM (Pulmatrix Inc) - Earnings per share trend in current year|PTHL - Earnings per share growth in current year|Earnings per share increase in current year APM (Aptorum Group Limited)|LYRA: Earnings growth in current year|Earnings per share trend in current year IBO (Impact BioMedical, Inc.)|Net earnings per share growth this year TNFA|Earnings per share growth this year YCBD (cbdMD Corp)|Earnings per share growth in current year Altamira Therapeutics (CYTO)|LIPO: Earnings per share trend in current year|Earnings growth in current year OPTN (OptiNose, Inc.)|Earnings per share increase in current year PIRS|Procaps - Earnings growth in current year|PTPI - Earnings growth in current year|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN Inc. - Earnings per share increase in current year|Earnings per share growth in current year TFF Pharmaceuticals
